Sotera Health reaffirms 2026 outlook, targets adjusted EPS of $0.95 to $1.01 amid European med device softness (NASDAQ:SHC)
· seekingalpha.com
Sotera Health Q3 2026 earnings: margin gains and reaffirmed guidance offset Europe medtech softness and FX risks.
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
If you have an ad-blocker enabled you may be blocked from ...